Health Condition 1: J453- Mild persistent asthma Health Condition 2: E109- Type 1 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For diabetic patients using insulin pens and syringes: All patients above 18-80 years Men and Women with Type 1 & 2 Diabetes Mellitus using insulin pens and syringes and willing to give consent to participate. For asthmatic patients using pressurized metered dose inhaler: All patients above 18-80 years Men and Women with Asthma using Pressurized Metered Dose Inhaler (pMDI) with or without the spacer and willing to give consent to participate.
Exclusion criteria
Exclusion criteria: A Patient who is not willing to give consent. A patient who is unable to speak and hear. A patient who is physically or mentally challenged. A patient who is bedridden. Pregnant Women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the pre-and post-response for KAP and their understanding regarding the practice of pharmaceutical aids.Timepoint: Two time points - Pre & Post Assessment. Pre Assessent: The baseline patient’s KAP regarding the use of insulin and inhalers will be assessed by using the KAP questionnaire. Post Assessment: After 6 months of implementation of video assisted tool by using KAP. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Manipal College of Pharmaceutical Sciences